 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children’s immunity |
| Ko Eun Lee, Sung-Ae Jung, Sang Hyoung Park, Chang Mo Moon, So Yeon Shim, Eun Soo Kim, Su Jin Cho, Seong-Eun Kim, Kwang Bum Cho, Suk-Kyun Yang |
|
Intest Res. 2019;17(2):237-243. Published online February 8, 2019 DOI: https://doi.org/10.5217/ir.2018.00071 |
|
Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children’s immunity Intestinal Research. 2019;17(2):237-243  Anti-TNF Alpha Agents and Breastfeeding Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. ;214-218 Preliminaries Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. ; Neutralisation of Soluble Tumor Necrosis Factor Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. ;83-89 Anti-TNF-a Therapy for Extraintestinal Manifestations of Inflammatory Bowel Disease Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. ;206-213 Author Index Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. ;234-234 Subject Index Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. ;235-240 Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease Gastroenterology. 2017;153(4):1163-1164 TNF Antagonist Trough Concentrations and Treatment Efficacy in Inflammatory Bowel Disease Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. ;100-103 Risk of Non-Hematologic Malignancy with Anti-TNF Therapy in Inflammatory Bowel Diseases Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. ;138-142 |
